Portrait of Meuser, Daniel

Meuser, Daniel

U.S. Representative PA-9 Republican Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
60
Buys / sells
23% / 77%
Last trade
Mar 25, 2026
Last filing
Apr 21, 2026

Latest disclosed trades

Latest 10 of 60
Ticker Type Traded
NVDA Sell Mar 25, 2026
NVDA Sell Feb 25, 2026
NVDA Sell Jan 30, 2026
NVDA Sell Jan 14, 2026
APTV Sell Feb 11, 2025
MSFT Sell Feb 11, 2025
GOOGL Sell Feb 11, 2025
NVDA Sell Feb 11, 2025
QCOM Sell Feb 11, 2025
MDLZ Sell Feb 11, 2025

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Meuser, Daniel stock trade activity

FilingIQ has indexed 60 congressional stock trade disclosures for Meuser, Daniel. The most recent disclosed transaction is dated Mar 25, 2026.

Across the full history, 14 purchases and 46 sales have been disclosed under the STOCK Act.

Top tickers traded by Meuser, Daniel

Frequently asked

How many stock trades has Meuser, Daniel disclosed?
FilingIQ tracks 60 Periodic Transaction Report disclosures for Meuser, Daniel, with the most recent dated Mar 25, 2026. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Meuser, Daniel a net buyer or net seller?
Across the disclosed trade history, 14 (23%) were purchases and 46 (77%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Meuser, Daniel come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.